RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Peak Pharmaceuticals Stock

Peak Pharmaceuticals EBIT 2024

Peak Pharmaceuticals EBIT

-163,300 USD

Ticker

PKPH

ISIN

US70469W1062

WKN

A14NHS

In 2024, Peak Pharmaceuticals's EBIT was -163,300 USD, a 137.63% increase from the -68,720 USD EBIT recorded in the previous year.

The Peak Pharmaceuticals EBIT history

YEAREBIT (undefined USD)
2022-0.16
2021-0.07
2020-0.01
2019-0.01
2018-0.03
2017-0.04
20161.09
2015-2.34
2014-2.5
2013-0.01
2012-0.02
2011-0.02
2010-0.02
2009-0.02
2008-0.01

Peak Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Peak Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Peak Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Peak Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Peak Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Peak Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Peak Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Peak Pharmaceuticals’s growth potential.

Peak Pharmaceuticals Revenue, EBIT and net profit per share

DatePeak Pharmaceuticals RevenuePeak Pharmaceuticals EBITPeak Pharmaceuticals Net Income
20220 undefined-163,300 undefined-164,970 undefined
20210 undefined-68,720 undefined-76,090 undefined
20200 undefined-5,540 undefined-15,010 undefined
20190 undefined-5,680 undefined-13,990 undefined
20180 undefined-27,820 undefined-28,410 undefined
20170 undefined-44,990 undefined-51,230 undefined
20160 undefined1.09 M undefined1.16 M undefined
20150 undefined-2.34 M undefined-2.31 M undefined
20140 undefined-2.5 M undefined-3.76 M undefined
20130 undefined-12,340 undefined-12,340 undefined
20120 undefined-20,220 undefined-20,220 undefined
20110 undefined-20,000 undefined-20,000 undefined
20100 undefined-20,000 undefined-20,000 undefined
20090 undefined-20,000 undefined-20,000 undefined
20080 undefined-10,000 undefined-10,000 undefined

Peak Pharmaceuticals stock margins

The Peak Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Peak Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Peak Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Peak Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Peak Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Peak Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Peak Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Peak Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Peak Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Peak Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Peak Pharmaceuticals Margin History

Peak Pharmaceuticals Gross marginPeak Pharmaceuticals Profit marginPeak Pharmaceuticals EBIT marginPeak Pharmaceuticals Profit margin
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %

Peak Pharmaceuticals Aktienanalyse

What does Peak Pharmaceuticals do?

Peak Pharmaceuticals Inc. is a company specializing in the development and marketing of pharmaceutical products. The company was founded in 2007 and is headquartered in Denver, Colorado. The company's history began with the vision of a group of experts in the pharmaceutical industry who aimed to develop innovative products that could improve people's lives. With their years of experience and expertise in drug research and development, they offered a promising perspective for the future. The company's business model is based on the creation of valuable active substances that cover a wide range of therapeutic applications. Peak Pharmaceuticals' products are designed to meet the complex needs of patients facing serious conditions such as cancer, pain, and neurological disorders. The company focuses on creating drugs that can increase therapy effectiveness and improve patients' quality of life. Peak Pharmaceuticals Inc. has developed several divisions in recent years to expand its presence in various markets. One significant area is the development of products for the cardiovascular field, focusing on the treatment of heart diseases. Another important area is the creation of drugs for the treatment of cancer, specifically tailored to the needs of patients with different types of cancer. Peak Pharmaceuticals also has a division for pain management, with products that can be used to relieve acute and chronic pain. The company has developed a wide range of pharmaceutical products based on innovative technologies such as nanotechnology, plant extracts, and other natural active substances. Peak Pharmaceuticals' products are the result of years of research and development, and they have been tested in clinical trials to ensure their effectiveness and safety. An example of a product from Peak Pharmaceuticals is PNTV, a cannabinoid-based pain medication. This medication was specifically developed for the treatment of pain in fibromyalgia and neuropathy and has been tested in clinical trials. Another example is B-link, a cancer medication manufactured using nanotechnology and can be used to treat various types of cancer. Overall, Peak Pharmaceuticals Inc. has established itself as a leading company in the pharmaceutical industry. The company strives to create innovative products that meet the medical needs of consumers and are significant to the healthcare industry. With a combination of passion, knowledge, and dedication, Peak Pharmaceuticals has made significant progress in recent times and looks forward to a promising future. Peak Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Peak Pharmaceuticals's EBIT

Peak Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Peak Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Peak Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Peak Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Peak Pharmaceuticals stock

How much did Peak Pharmaceuticals achieve in EBIT for the current year?

In the current year, Peak Pharmaceuticals has achieved an EBIT of -163,300 USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Peak Pharmaceuticals.

How has the EBIT of Peak Pharmaceuticals developed in recent years?

The EBIT of Peak Pharmaceuticals has increased by 137.631% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Peak Pharmaceuticals?

The EBIT of Peak Pharmaceuticals is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Peak Pharmaceuticals pay?

Over the past 12 months, Peak Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Peak Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Peak Pharmaceuticals?

The current dividend yield of Peak Pharmaceuticals is .

When does Peak Pharmaceuticals pay dividends?

Peak Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Peak Pharmaceuticals?

Peak Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Peak Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Peak Pharmaceuticals located?

Peak Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Peak Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Peak Pharmaceuticals from 10/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/9/2024.

When did Peak Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/9/2024.

What was the dividend of Peak Pharmaceuticals in the year 2023?

In the year 2023, Peak Pharmaceuticals distributed 0 USD as dividends.

In which currency does Peak Pharmaceuticals pay out the dividend?

The dividends of Peak Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Peak Pharmaceuticals

Our stock analysis for Peak Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Peak Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.